Back to search

France· FR:60787186

VOXZOGO 0,4 mg, poudre et solvant pour solution injectable

A vosoritide product containing vosoritide, registered in France by BIOMARIN INTERNATIONAL LIMITED (IRLANDE), on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC M05BX07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVOXZOGO 0,4 mg, poudre et solvant pou…ATCM05BX07REGISTER NO.FR:60787186PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Vosoritide is registered in 10 of 19 countries.

Countries holding a registration under ATC M05BX07 (vosoritide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose

Vosoritide · ATC M05BX07

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
VOSORITIDE
Manufacturer
BIOMARIN INTERNATIONAL LIMITED (IRLANDE)
Country
France (FR)
ATC code
M05BX07
ATC class
Vosoritide
Defined daily dose
0.4 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930236673
    10 flacons en verre de 0,4 mg + 10 seringues préremplies en verre de 0,5 ml + 10 aiguilles + 10 seringues d'administration
    EUR 5.28

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5bca2247-e6c0-40fc-a146-97adc0144c90
GET /v1/drugs/5bca2247-e6c0-40fc-a146-97adc0144c90?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60787186",
  "date_amm": "2021-08-26",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/21/1577",
  "substance": "VOSORITIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about vosoritide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.